3 news items
Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress
AGIO
14 May 24
a robust clinical pipeline of investigational medicines with programs in alpha- and beta-thalassemia, sickle cell disease, pediatric PK deficiency
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
AGIO
3 May 24
and leadership in the field of cellular metabolism and rare hematologic diseases, Agios is advancing a robust clinical pipeline of investigational
Agios Reports Business Highlights and First Quarter 2024 Financial Results
AGIO
2 May 24
of cellular metabolism and rare hematologic diseases, Agios is advancing a robust clinical pipeline of investigational medicines with programs in alpha
- Prev
- 1
- Next